<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Linecker M</dc:creator>
  <dc:creator>Stavrou GA</dc:creator>
  <dc:creator>Oldhafer KJ</dc:creator>
  <dc:creator>Jenner RM</dc:creator>
  <dc:creator>Seifert B</dc:creator>
  <dc:creator>Lurje G</dc:creator>
  <dc:creator>Bednarsch J</dc:creator>
  <dc:creator>Neumann U</dc:creator>
  <dc:creator>Capobianco I</dc:creator>
  <dc:creator>Nadalin S</dc:creator>
  <dc:creator>Robles-Campos R</dc:creator>
  <dc:creator>de Santibañes E</dc:creator>
  <dc:creator>Malagó M</dc:creator>
  <dc:creator>Lesurtel M</dc:creator>
  <dc:creator>Clavien PA</dc:creator>
  <dc:creator>Petrowsky H</dc:creator>
  <dc:date>2016</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">OBJECTIVES
To create a prediction model identifying futile outcome in ALPPS (Associating Liver Partition and Portal vein ligation for Staged hepatectomy) before stage 1 and stage 2 surgery.


BACKGROUND
ALPPS is a 2-stage hepatectomy, which incorporates parenchymal transection at stage 1 enabling resection of extensive liver tumors. One of the major criticisms of ALPPS is the associated high mortality rate up to 20%.


METHODS
Using the International ALPPS Registry, a risk analysis for futile outcome (defined as 90-day or in-hospital mortality) was performed. Futility was modeled using multivariate regression analysis and a futility risk score formula was computed on the basis of the relative size of logistic model regression coefficients.


RESULTS
Among 528 ALPPS patients from 38 centers, a futile outcome was observed in 47 patients (9%). The pre-stage 1 model included age 67 years or older [odds ratio (OR) = 5.7], and tumor entity (OR = 3.8 for biliary tumors) as independent predictors of futility from multivariate analysis. For the pre-stage 1 model scores of 0, 1, 2, 3, 4 and 5 were associated with futile risk of 2.7%, 4.9%, 8.6%, 15%, 24%, and 37%. The pre-stage 2 model included major complications (grade ≥ 3b) after stage 1 (OR = 3.4), serum bilirubin (OR = 4.4), serum creatinine (OR = 5.4), and cumulative pre-stage 1 risk score (OR = 1.9). The model predicted futility risk of 5%, 10%, 20%, and 50% for patients with scores of 3.9, 4.7, 5.5, and 6.9, respectively.


CONCLUSIONS
Both models have an excellent prediction to assess the individual risk of futile outcome after ALPPS surgery and can be used to avoid futile use of ALPPS.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/255615</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1097/SLA.0000000000001914</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/27455156</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Annals of surgery. - 2016</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Hepatectomy</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Hospital Mortality</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Ligation</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Liver Neoplasms</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Logistic Models</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Medical Futility</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Operative Time</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Portal Vein</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Risk Assessment</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Risk Factors</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Time Factors</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Treatment Outcome</dc:subject>
  <dc:title xmlns:ns18="xml" ns18:lang="en">The ALPPS Risk Score: Avoiding Futile Use of ALPPS.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
